This study highlights the novel finding that 5-formamidoimidazole-4-carboxamide ribotide suppresses BRCA1 expression by inhibiting METTL1-mediated m7G modification, ultimately leading to the inhibition of HGSOC cell proliferation and tumor growth. This evidence concerns the gene METTL1 and neoplasm.